TrialThe Lancet. Microbe2022

Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial.

Adam P Dale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.